Study or sub-group | 30 days | 90 days | Mean difference IV, fixed (95% CI) | ||||
---|---|---|---|---|---|---|---|
Mean | SD | Total, N | Mean | SD | Total, N | ||
Lipid-lowering medication | |||||||
Taitel et al (2012)32 | 0.671 | 0.278 | 12 136 | 0.819 | 0.194 | 2162 | −0.15 (−0.16 to −0.14) |
Antihypertensive medication | |||||||
Taitel et al (2012)32 | 0.774 | 0.292 | 33 009 | 0.910 | 0.174 | 5835 | −0.14 (−0.14 to −0.13) |
Diabetic medication | |||||||
Taitel et al (2012)32 | 0.755 | 0.289 | 11 842 | 0.875 | 0.19 | 1511 | −0.12 (−0.13 to −0.11) |
Antidepressant medication | |||||||
Taitel et al (2012)32 | 0.611 | 0.295 | 7017 | 0.817 | 0.196 | 266 | −0.21 (−0.23 to −0.18) |
Digoxin | |||||||
Steiner et al (1993)31 | 0.897 | 0.349 | 27 | 1.130 | 0.214 | 46 | −0.23 (−0.38 to −0.09) |
Mixed medications | |||||||
Jiang et al (2007)26 | 0.399 | 2.868 | 955 | 0.703 | 2.868 | 730 | −0.30 (−0.58 to −0.03) |
IV = inverse variance. N = the total number of participants evaluated in each arm of the study. SD = standard deviation.